Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)

NCT00811031 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Taxotere
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]